Interpace Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!About IDXG
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.
CEOJack E. Stover
CEOJack E. Stover
Employees89
Employees89
HeadquartersParsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded1986
Founded1986
Employees89
Employees89
IDXG Key Statistics
Market cap33.23M
Market cap33.23M
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume573.44K
Average volume573.44K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.12
52 Week high$1.12
52 Week low$0.381
52 Week low$0.381
IDXG News
TipRanks 3d
Interpace Biosciences presents two posters at ATA meetingInterpace Biosciences (IDXG) presented two new scientific posters at the 2025 American Thyroid Association Annual Meeting. The first poster, “Utilizing Archival...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IDXG. This list is generated using Robinhood data, and it’s not a recommendation.